Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 15/20 | 0.68 |
| ▸ | CHRM3 | P20309 | 8/20 | 0.68 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.53 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22829188 | 1.00 | ADRB2 (0.68) | ADRB2CHRM3ADRB1ADRB3 | |
| SCHEMBL22829074 | 0.94 | ADRB2 (0.75) | ADRB2CHRM3 | |
| SCHEMBL22829075 | 0.94 | ADRB2 (0.75) | ADRB2CHRM3 | |
| SCHEMBL22829168 | 0.91 | ADRB2 (0.70) | ADRB2CHRM3ADRB1 | |
| SCHEMBL22829170 | 0.91 | ADRB2 (0.70) | ADRB2CHRM3ADRB1 | |
| SCHEMBL22829100 | 0.90 | ADRB2 (0.68) | ADRB2CHRM3ADRB1 | |
| SCHEMBL22829099 | 0.90 | ADRB2 (0.68) | ADRB2CHRM3ADRB1 | |
| SCHEMBL22829246 | 0.88 | ADRB2 (0.63) | ADRB2CHRM3ADRB1 | |
| SCHEMBL22829245 | 0.88 | ADRB2 (0.63) | ADRB2CHRM3ADRB1 | |
| SCHEMBL22829110 | 0.88 | ADRB2 (0.60) | ADRB2CHRM3ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3484879-B1 | HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | CHIESI FARM SPA (IT) | 2020-12-30 | — | — | EP | claimed |
| EP-3484879-B1 | HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | CHIESI FARM SPA (IT) | 2020-12-30 | — | — | EP | disclosed |